Solving Lutein: How 3D Electron Diffraction Enabled a Breakthrough Patent

We are thrilled to share an extraordinary milestone achieved by our partner ELDICO Scientific, alongside an international research consortium comprising TeraCrystal SRL (Cluj-Napoca, Romania), the Iuliu Hațieganu University of Medicine and Pharmacy (Romania), and the Board of Supervisors of Louisiana StateUniversity and Agricultural and Mechanical College (USA). 

The consortium has recently filed the PCT patent WO 2025/106389 A1 (published May 2025), which discloses novel crystalline and cocrystal forms of lutein with significantly enhanced stability and bioavailability. At the heart of this research was the structural characterization achieved through three-dimensional electron diffraction (3D-ED), conducted entirely at room temperature using the ELDICO ED-1. 

The Challenge: Lutein-Uncooperative Compound 

As a xanthophyll carotenoid, lutein is a plant pigment characterized by a chain of ten conjugated carbon-carbon double bonds. In the human body, it concentrates within the inner retinal layer of the macula, serving as a vital antioxidant and absorbing short-wavelength blue light. Numerous studies consistently link a diet rich in lutein to a lower risk of developing cataracts and age-related macular degeneration (AMD). 

However, its pharmaceutical development has long been hindered by its tricky physicochemical properties. Lutein is water-insoluble, poorly absorbed in vivo, and extremely sensitive to light, oxygen, and heat—requiring storage at −20°C to prevent degradation. 

Prior crystal structure determinations of lutein could only be achieved at cryogenic temperatures (113 K) incorporating ethanol or methanol, which distorted the true conformation of pure lutein. 

The Solution: 3D-ED at Room Temperature with ELDICO ED-1 

To solve this structural problem, the research team turned to Three-Dimensional Electron Diffraction (3D-ED). Because electrons interact with matter much more strongly than X-rays, complete structural datasets can be extracted from nanocrystals samples orders of magnitude smaller than those required for for single-crystal XRD. 

Using the ELDICO ED-1—the world’s first dedicated electron diffractometer — the experiment was elegantly straightforward. Operating at room temperature (293 K) with no cryogenic handling and minimal sample preparation, the ED-1’s controlled illumination and highly sensitive hybrid-pixel detector successfully captured the weak scattering signals of the fragile lutein nanocrystals without causing beam damage. 

The result? The first-ever crystal structure of solvent-free, pure crystalline lutein measured at ambient conditions. The data revealed a compact triclinic P-1 structure with less than 0.5% solvent-accessible void volume.  

Pharmaceutical Impact 

This structural insight allowed the consortium to develop four new cocrystal forms of lutein (with gallic acid, gentisic acid, 5- hydroxytryptophan (5-HTP), and DL-α-tocopherol). The pharmaceutical results are groundbreaking: 

• Massively Improved Bioavailability: In in vitro diffusion testing, the lutein–gallic acid cocrystal achieved a 20-fold increase in concentration compared to unprocessed lutein, while pure crystalline lutein showed a 7-fold improvement. 

• Proven In Vivo Efficacy:  When tested in vivo on rat pups with selenite-induced cataracts, the results were remarkable: applying a bioadhesive hydrogel containing crystalline lutein lowered average cataract severity by roughly 70% compared to the untreated control group (p < 0.001). Additionally, the three tested cocrystal variations (gallic acid, gentisic acid, and 5-HTP) all demonstrated highly significant therapeutic effects, cutting cataract severity by approximately 54% to 57% (p < 0.001). This research is paving the way for advanced human ocular therapies for AMD and cataract prevention. 

Redefining Pharmaceutical Solid-State Workflows 

This patent is a definitive proof for what the ELDICO ED-1 can achieve within a full CMC  workflow. It proves that even the most beam-sensitive and crystallization-resistant compounds can yield complete, validated crystal structures under ambient conditions when the right instrument is used. 

If you would like to know more about the ELDICO ED-1 technical features, click here